Core Viewpoint - The National Market Supervision Administration emphasizes the need for fair competition and plans to conduct reviews and investigations to rectify policies that hinder a unified market and fair competition by 2025 [1] Group 1: Fair Competition Measures - A fair competition review will be organized in 2025 to address policies that obstruct market unity and fair competition [1] - The administration aims to investigate and rectify various policies that may lead to monopolistic practices, particularly in the pharmaceutical sector [1] Group 2: Antitrust Actions - The agency plans to address a series of monopolistic cases in the pharmaceutical industry, which is expected to lead to significant price reductions for involved drugs [1] - A total of 14,600 cases of unfair competition will be investigated and handled [1] Group 3: Market Regulation - There will be a comprehensive effort to mitigate "involution-style" competition, focusing on cost investigations, price checks, and guidance for key enterprises [1] - The initiative aims to effectively cool down "price wars" and "subsidy wars" in the market [1]
市场监管总局：2025年查办1.46万件反不正当竞争案件
2 1 Shi Ji Jing Ji Bao Dao·2026-02-05 05:58